3M INDIA LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30,468 INR | +1.48% |
|
+2.13% | -18.34% |
| Apr. 01 | 3M India Limited Announces Agreements Executes in Relation to the Health Care Business | CI |
| Feb. 12 | 3M India Posts Gains in Fiscal Q3 Consolidated Net Profit | MT |
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 60.82 times its estimated earnings per share for the ongoing year.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Consumer Goods Conglomerates
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -18.34% | 4.11B | - | ||
| +10.48% | 858B | D+ | ||
| 0.00% | 239B | - | C | |
| +26.79% | 177B | B | ||
| -8.10% | 126B | B- | ||
| +42.48% | 86.04B | B+ | ||
| -6.81% | 72.93B | B | ||
| -11.72% | 53.4B | C+ | ||
| -24.57% | 38.44B | - | - | |
| +42.57% | 36.78B | A |
Investor Rating
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
- Stock Market
- Equities
- 3MINDIA Stock
- 3MINDIA Stock
- Ratings 3M India Limited
